Therapeutic Play Kit
Find information on
GAMMAGARD Therapy
Find detailedGAMMAGARD TherapyGARD your patients
A specially formulated 10% IVIG therapy with demonstrated efficacy, safety, and tolerability for patients – children to adults* – with primary immunodeficiency.1,2
Features of GAMMAGARD Therapy
Efficacy, tolerability, safety and convenience – features of GAMMAGARD therapy to consider in selecting an IVIG therapy for your patients.
GAMMAGARD Options
GAMMAGARD therapy has three options, including one for patients who require low IgA.
Using GAMMAGARD LIQUID Therapy
For information about dosing, administration and storage of GAMMAGARD LIQUID therapy.
GAMMAGARD Billing and Reimbursement
Learn about coverage, coding, and reimbursement, as well as billing instructions.
Ordering GAMMAGARD Therapy
You can order GAMMAGARD therapy by phone, fax, mail or online.
* Clinical study evaluated patients 6-72 years of age.
GAMMAGARD LIQUID is indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity. These include but are not limited to congenital X-linked agammaglobulinemia, common variable immunodeficiency, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
Please see the detailed Important Risk Information and Full Prescribing Information for GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] for full prescribing details.
- GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] 10% package insert. Westlake Village, CA. Baxter International Inc.; October 2009.
- Church JA, Leibl H, Stein MR, et al, and the US-PID-IGIV 10% Study Group. Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiency. Journal of Clinical Immunology 2006;26:388-395.
